cangrelor

Ligand id: 1776

Name: cangrelor

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: cangrelor

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 17
Hydrogen bond donors 7
Rotatable bonds 16
Topological polar surface area 335.94
Molecular weight 774.95
XLogP -0.92
No. Lipinski's rules broken 3

Molecular properties generated using the CDK

Classification
Compound class Synthetic organic
Approved drug? Yes (FDA & EMA (2015))
IUPAC Name
[dichloro-[[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(2-methylsulfanylethylamino)-2-(3,3,3-trifluoropropylsulfanyl)purin-9-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]phosphonic acid
International Nonproprietary Names
INN number INN
7883 cangrelor
Synonyms
AR-C69931MX | ARL69931 | Kengreal®
Database Links
BindingDB Ligand 50118225
CAS Registry No. 163706-06-7 (source: Scifinder)
ChEMBL Ligand CHEMBL334966
GtoPdb PubChem SID 135650051
PubChem CID 9854012
Search Google for chemical match using the InChIKey PAEBIVWUMLRPSK-IDTAVKCVSA-N
Search Google for chemicals with the same backbone PAEBIVWUMLRPSK
Search PubMed clinical trials cangrelor
Search PubMed titles cangrelor
Search PubMed titles/abstracts cangrelor
Search UniChem for chemical match using the InChIKey PAEBIVWUMLRPSK-IDTAVKCVSA-N
Search UniChem for chemicals with the same backbone PAEBIVWUMLRPSK
Wikipedia Cangrelor
Comments
Cangrelor is an intravenously administered antiplatelet compound.